When decision-makers need to understand a medical technology, they ask the most credentialed authorities they can find. These two professors — both former directors at the highest levels of Israel's healthcare system — independently reviewed PEMF and reached the same conclusion.
The Context
In Israel, medical device integration into hospitals and clinics requires sign-off from the Ministry of Health. These letters were written by two of the most qualified individuals in Israel's medical establishment — not to sell a product, but to give an honest professional assessment of the technology.
Both independently concluded that PEMF deserves a place in clinical practice. Both cite peer-reviewed literature. Both reference FDA approval and international adoption. For a Philippine clinic investor, these documents serve as due diligence done by people who had every incentive to be conservative.
Prof. Grotto was the number-two official in Israel's Ministry of Health — responsible for all public health policy. His review of PEMF is not a paid endorsement. It is a formal medical opinion from someone who spent a decade evaluating which technologies deserve integration into Israel's healthcare system. He cites Mayo Clinic data showing 22% reduction in hospitalization and ROI within 5.4 months.
Prof. Zeilig ran the neurological rehabilitation department at Sheba Medical Center — Tel Hashomer — one of the largest and most prestigious hospitals in the Middle East. His review is a clinician's assessment: he cites 7 specific peer-reviewed studies from JAMA, The Lancet, Rheumatology, and other top journals, and draws a direct clinical conclusion.
Investment Package
These letters are part of the investor package. Request the full brief — device specs, ROI model, clinical protocols, and both professor letters — in one document.
Request Investment Brief →